Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset.

Savanna AndreouElena PanayiotouKyriaki MichailidouPanayiota PirpaAndreas HadjisavvasAdonis El SalloukhDaniel R BarnesAntonis AntoniouPetros AgathangelouKatia PapastavrouChristodoulou Kyproula George A TantelesTheodoros Kyriakides

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2018)

ATTRV30M neuropathy has a rising prevalence in Cyprus due to improved survival of patients. Late onset complications are becoming a major problem. Complement C1q appears to be a modifier in this disease.

Keyphrases

late onset
risk factors
end stage renal disease
early onset
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported